Document Detail

Early regression of left ventricular hypertrophy after treatment with esmolol in an experimental rat model of primary hypertension.
MedLine Citation:
PMID:  23364336     Owner:  NLM     Status:  Publisher    
Certain β-adrenergic blockers have proven useful in the regression of ventricular remodeling when administered as long-term treatment. However, early regression of left ventricular hypertrophy (LVH) has not been reported, following short-term administration of these drugs. We tested the hypothesis that short-term administration of the cardioselective β-blocker esmolol induces early regression of LVH in spontaneously hypertensive rats (SHR). Fourteen-month-old male SHRs were treated i.v. with vehicle (SHR) or esmolol (SHR-E) (300 μg kg(-1) min(-1)). Age-matched vehicle-treated male Wistar-Kyoto (WKY) rats served as controls. After 48 h, left ventricular morphology and function were assessed using M-mode echocardiograms (left ventricular mass index (LVMI), ejection fraction and transmitral Doppler (early-to-atrial filling velocity ratio (E/A), E-wave deceleration time (Edec time)). The standardized uptake value (SUV) was applied to evaluate FDG (2-deoxy-2[18F]fluoro-D-glucose) uptake by the heart using PET/CT. Left ventricular subendocardial and subepicardial biopsies were taken to analyze changes in cross-sectional area (CSA) of left ventricular cardiomyocytes and the fibrosis was expressed as collagen volume fraction (CVF). LVMI was lower in SHR-E with respect to SHR (P=0.009). There were no significant differences in EF, E/A ratio or Edec time in SHR-E compared with SHR (P=0.17, 0.55 and P=0.80, respectively). PET acquisitions in SHR-E showed lower (18)F-FDG uptake than SHR (P=0.003). Interestingly, there were no significant differences in SUV in either SHR-E or WKY (P=0.63). CSA in subendocardial and subepicardial regions was minor in SHR-E with respect to SHR (P<0.001), and there were no significant differences in CVF between both groups. Esmolol reverses early LVH in the SHR model of stable compensated ventricular hypertrophy. This is the first study to associate early regression of LVH with administration of a short-term β-blocker.Hypertension Research advance online publication, 31 January 2013; doi:10.1038/hr.2012.191.
Begoña Quintana-Villamandos; María Jesús Delgado-Martos; Jose Javier Sánchez-Hernández; Jose Juan Gómez de Diego; María Del Carmen Fernández-Criado; Fernando Canillas; Antonia Martos-Rodríguez; Emilio Delgado-Baeza
Related Documents :
24513476 - Impact of the angiographic mechanisms underlying periprocedural myocardial infarction a...
23965746 - Sulfonylurea receptor 1 expression in human cerebral infarcts.
23453106 - Risk stratification in patients with unstable angina using absolute serial changes of 3...
24125106 - Gremlin-1 identifies fibrosis and predicts adverse outcome in patients with heart failu...
3905046 - Has 'obstruction' hindered our understanding of hypertrophic cardiomyopathy?
1288866 - Ischaemic preconditioning is not dependent on neutrophils or glycolytic substrate at re...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-31
Journal Detail:
Title:  Hypertension research : official journal of the Japanese Society of Hypertension     Volume:  -     ISSN:  1348-4214     ISO Abbreviation:  Hypertens. Res.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-31     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9307690     Medline TA:  Hypertens Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
1] Department of Anesthesiology, Hospital General Universitario Gregorio Marañón, Madrid, Spain [2] Department of Pharmacology, Faculty of Medicine Universidad Complutense, Madrid, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of IR laser on myoblasts: a proteomic study.
Next Document:  Carbonyl stress induces hypertension and cardio-renal vascular injury in Dahl salt-sensitive rats.